REG - Surgical Innovations - Posting of 2021 Annual Report & Accounts

Surgical InnovationsAnnouncement

25/05/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220525:nRSY6750Ma&default-theme=true

RNS Number : 6750M  Surgical Innovations Group PLC  25 May 2022

 

Surgical Innovations Group plc

("Surgical Innovations", "SI" or the "Company")

 

Posting of 2021 Annual Report & Accounts
Notice of Annual General Meeting

 

Surgical Innovations Group plc (AIM: SUN), the designer, manufacturer and
distributor of innovative medical technology for minimally invasive surgery
("MIS"), confirms that the Annual Report and Accounts for the year ended 31
December 2021 ("2021 Annual Report") and the Notice of the 2022 Annual General
Meeting ("AGM") have now been published and can be accessed via the "Investor
Centre" section of the Company's website at: www.sigroupplc.com
(http://www.sigroupplc.com/)

 

The 2021 Annual Report, the Notice of AGM and details voting by proxy will be
posted to shareholders who have not consented to receive electronic
communications.

 

Notice of AGM

The AGM is to be held on Monday 27 June 2022 at 10:00 am at the Company's
offices at Clayton Wood House, 6 Clayton Wood Bank, Leeds, LS16 6QZ and will
consider the Resolutions set out in the Notice of AGM.

 

We encourage shareholders to participate in the AGM by voting by proxy. As it
is not always possible to attend and ask questions in person, we will provide
an opportunity for shareholder engagement prior to the AGM. In order to
facilitate this, if you are a shareholder and would like to ask the Board a
question, please submit your questions to the following email:
si@surginno.co.uk, (mailto:si@surginno.co.uk) titled 'AGM'. Shareholders
should note that any questions in relation to confidential or potentially
price sensitive matters cannot be addressed.

 

The proxy appointment form should be returned, or the electronic proxy
appointment instruction transmitted, no later than 10:00 am on Thursday 23
June 2022. More details can be found in the Notice of AGM.

 

 

 

For further information please contact:

 

 

 Surgical Innovations Group plc    www sigroupplc com (http://www.sigroupplc.com/)
 David Marsh, CEO                  Tel: 0113 230 7597
 Charmaine Day, CFO

 Singer Capital Markets (Nominated Adviser & Broker)                                    Tel: 020 7496 3000
 Aubrey Powell / Rachel Hayes

 Walbrook PR (Financial PR & Investor Relations)               Tel: 020 7933 8780 or
                                                               si@walbrookpr.com (mailto:si@walbrookpr.com)
 Paul McManus / Lianne Applegarth  Mob: 07980 541 893 / 07584 391 303

 

About Surgical Innovations Group plc

The Group specialises in the design, manufacture, sale and distribution of
innovative, high quality medical products, primarily for use in minimally
invasive surgery. Our product and business development is guided and supported
by a key group of nationally and internationally renowned surgeons across the
spectrum of minimally invasive surgical activity.

 

We design and manufacture and source our branded port access systems, surgical
instruments and retraction devices which are sold directly in the UK home
market through our subsidiary, Elemental Healthcare, and exported widely
through a global network of trusted distribution partners. Many of our
products in this field are based on a "resposable" concept, in which the
products are part reusable, part disposable, offering a high quality and
environmentally responsible solution at a cost that is competitive against
fully disposable alternatives.

 

Elemental also has exclusive UK distribution for a select group of specialist
products employed in laparoscopy, bariatric and metabolic surgery, hernia
repair and breast reconstruction.

 

In addition, we design and develop medical devices for carefully selected OEM
partners and have also collaborated with a major UK industrial partner to
provide precision engineering solutions to complex problems outside the
medical arena.

 

We aim for our brands to be recognised and respected by healthcare
professionals in all major geographical markets in which we operate and
provide by development, partnership or acquisition a broad portfolio of cost
effective, procedure specific surgical instruments and implantable devices
that offer reliable solutions to genuine clinical needs in the operating
theatre environment.

 

Further information

Further details of the Group's businesses and products are available on the
following websites:

www.sigroupplc.com (http://www.sigroupplc.com)

www.surginno.com (http://www.surginno.com)

www.elementalhealthcare.co.uk (http://www.elementalhealthcare.co.uk)

 

To receive regular updates by email, please contact si@walbrookpr.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCAIMRTMTMTBFT